Legend Biotech (LEGN) Dividends Paid - Common (2019 - 2025)
Legend Biotech's (LEGN) quarterly Dividends Paid - Common came in at $12.3 million in Q3 2025, down 95.23% YoY from $258.0 million in Q3 2024, and up 107.03% on a QoQ basis from -$175.1 million in Q2 2025.
Legend Biotech (LEGN) Dividends Paid - Common (2019 - 2025) Analysis & Trends
Legend Biotech (LEGN) has 7 years of Dividends Paid - Common data on file, last reported at $12.3 million in Q3 2025.
- Quarterly Dividends Paid - Common fell 95.23% year-over-year to $12.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $536.9 million (up 183.28% YoY) and the FY2021 annual result came in at $688.9 million, up 51.19% from the prior year.
- Dividends Paid - Common grew to $12.3 million in Q3 2025, from -$175.1 million in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $897.6 million in Q1 2024 to a low of -$696.3 million in Q2 2024.
- A 5-year average of $221.4 million and a median of $317.9 million in 2022 frame the typical range for Dividends Paid - Common.
- Annual changes were most pronounced in 2023 — Dividends Paid - Common surged 28702.16% — and 2024, when it tumbled 221.49%.
- Tracing LEGN's Dividends Paid - Common over 5 years: stood at $688.9 million in 2021, then slumped by 37.16% to $433.0 million in 2022, then plunged by 162.3% to -$269.7 million in 2023, then jumped by 195.66% to $258.0 million in 2024, then plunged by 95.23% to $12.3 million in 2025.
- The last three Dividends Paid - Common figures came in at $12.3 million (Q3 2025), -$175.1 million (Q2 2025), and $441.7 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 34.60 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 12.31 Mn |
| Sep 30, 2025 | 12.31 Mn |
| Jun 30, 2025 | -175.12 Mn |
| Jun 30, 2025 | -175.12 Mn |
| Mar 31, 2025 | 441.70 Mn |
| Mar 31, 2025 | 441.70 Mn |
| Sep 30, 2024 | 258.02 Mn |
| Sep 30, 2024 | 258.02 Mn |
| Jun 30, 2024 | -696.32 Mn |
| Jun 30, 2024 | -696.32 Mn |
| Mar 31, 2024 | 897.57 Mn |
| Mar 31, 2024 | 897.57 Mn |
| Sep 30, 2023 | -269.74 Mn |
| Sep 30, 2023 | -269.74 Mn |
| Jun 30, 2023 | 573.16 Mn |
| Jun 30, 2023 | 573.16 Mn |
| Mar 31, 2023 | 660.05 Mn |
| Mar 31, 2023 | 660.05 Mn |
| Sep 30, 2022 | 432.96 Mn |
| Sep 30, 2022 | 432.96 Mn |